Cystitis-Related Bladder Pain Involves ATP-Dependent HMGB1 Release from Macrophages and Its Downstream H
Acrolein
/ metabolism
Adenosine Triphosphate
/ metabolism
Animals
Calcium Channels, T-Type
/ genetics
Cyclophosphamide
/ adverse effects
Cystathionine gamma-Lyase
/ metabolism
Cystitis, Interstitial
/ chemically induced
Disease Models, Animal
Female
HMGB1 Protein
/ metabolism
Macrophages
/ metabolism
Male
Mice
Mice, Knockout
Receptor for Advanced Glycation End Products
/ metabolism
Signal Transduction
/ genetics
Sulfites
/ metabolism
Up-Regulation
/ genetics
Adenosine triphosphate (ATP)
Cav3.2 T-type Ca2+ channel
cyclophosphamide (CPA)
cystathionine-γ-lyase (CSE)
high mobility group box 1 (HMGB1)
hydrogen sulfide (H2S)
interstitial cystitis/bladder pain syndrome (IC/BPS)
macrophage
reactive oxygen species (ROS)
receptor for advanced glycation end products (RAGE)
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
22 07 2020
22 07 2020
Historique:
received:
13
07
2020
accepted:
19
07
2020
entrez:
26
7
2020
pubmed:
28
7
2020
medline:
11
3
2021
Statut:
epublish
Résumé
Cystitis-related bladder pain involves RAGE activation by HMGB1, and increased Ca
Identifiants
pubmed: 32707767
pii: cells9081748
doi: 10.3390/cells9081748
pmc: PMC7463894
pii:
doi:
Substances chimiques
Ager protein, mouse
0
Cacna1h protein, mouse
0
Calcium Channels, T-Type
0
HMGB1 Protein
0
HMGB1 protein, mouse
0
Receptor for Advanced Glycation End Products
0
Sulfites
0
Acrolein
7864XYD3JJ
Adenosine Triphosphate
8L70Q75FXE
Cyclophosphamide
8N3DW7272P
Cystathionine gamma-Lyase
EC 4.4.1.1
hydrogen sulfite
OJ9787WBLU
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
J Neuroimmune Pharmacol. 2017 Dec;12(4):693-707
pubmed: 28755135
Urology. 2007 Apr;69(4 Suppl):24-33
pubmed: 17462476
Neuropharmacology. 2014 Apr;79:112-8
pubmed: 24262631
J Neuroinflammation. 2019 Oct 30;16(1):199
pubmed: 31666085
Horm Cancer. 2018 Oct;9(5):295-325
pubmed: 29987748
Eur J Pharmacol. 2019 Sep 5;858:172487
pubmed: 31229535
Sci Rep. 2018 Jan 30;8(1):1838
pubmed: 29382907
Urology. 2014 May;83(5):1030-4
pubmed: 24767520
Biochem Biophys Res Commun. 2014 Feb 28;445(1):225-9
pubmed: 24508802
Mol Med. 2015 Feb 05;20:569-78
pubmed: 25222915
J Pharmacol Sci. 2016 Feb;130(2):139-42
pubmed: 26883456
Br J Pharmacol. 2012 Jan;165(1):183-96
pubmed: 21675966
J Neuroinflammation. 2012 Jul 23;9:180
pubmed: 22824385
Eur J Pain. 1999 Jun;3(2):141-149
pubmed: 10700343
EMBO J. 2003 Oct 15;22(20):5551-60
pubmed: 14532127
PLoS One. 2016 Jun 09;11(6):e0156468
pubmed: 27281030
Br J Pharmacol. 2012 Oct;167(4):917-28
pubmed: 22646666
J Immunol. 2014 Dec 15;193(12):6114-23
pubmed: 25392528
J Surg Res. 2012 Jun 1;175(1):88-100
pubmed: 21571302
Am J Physiol Renal Physiol. 2016 Jul 1;311(1):F85-93
pubmed: 27122537
Naunyn Schmiedebergs Arch Pharmacol. 2011 Sep;384(3):265-75
pubmed: 21789632
FASEB J. 2007 Dec;21(14):3904-16
pubmed: 17628015
J Urol. 2000 Jun;163(6):2002-7
pubmed: 10799247
Pain. 2011 Jun;152(6):1373-81
pubmed: 21396778
Pain. 2007 Nov;132(1-2):74-81
pubmed: 17346888
PLoS One. 2012;7(7):e41932
pubmed: 22860034
Prog Neurobiol. 2006 Apr;78(6):327-46
pubmed: 16697102
Prog Neurobiol. 2001 Oct;65(2):107-34
pubmed: 11403876
J Immunol. 2018 Feb 1;200(3):1159-1168
pubmed: 29255078
Neuropharmacology. 2018 Oct;141:201-213
pubmed: 30179591
EMBO J. 2010 Jul 21;29(14):2290-300
pubmed: 20562826
J Med Chem. 2012 Nov 26;55(22):9576-88
pubmed: 23075067
Biochem Pharmacol. 2004 Sep 15;68(6):1255-67
pubmed: 15313424
Toxicology. 2018 Jan 15;393:102-112
pubmed: 29129814
Cell Biol Toxicol. 2007 Sep;23(5):303-12
pubmed: 17225077
Clin Exp Pharmacol Physiol. 2018 Apr;45(4):355-361
pubmed: 29044685
J Leukoc Biol. 2009 Sep;86(3):633-43
pubmed: 19454652
J Pharmacol Sci. 2019 Jul;140(3):310-312
pubmed: 31492577
Bioorg Med Chem. 2018 Aug 15;26(15):4410-4427
pubmed: 30031654